Augmented Reality Treadmill Training in Patients With Parkinson's Disease
NCT ID: NCT04108741
Last Updated: 2023-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2020-09-15
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Progressive Treadmill Training Protocol for Parkinson's Disease
NCT05902065
Stability and Balance in Locomotion Through Exercise
NCT01856244
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
NCT04117737
Virtual Reality-based Interactive Treadmill Gait Training System for Parkinson's Disease
NCT03686462
Feasibility and Effectiveness of Virtual Reality & Use of Body Weight Support Treadmill Training in Parkinson's Disease
NCT02516644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treadmill training with augmented reality dual tasking
C-Mill augmented reality treadmill training
PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.
treadmill training with random number generation dual tasking
C-Mill augmented reality treadmill training
PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.
treadmill training
C-Mill augmented reality treadmill training
PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-Mill augmented reality treadmill training
PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parkinson´s disease without dementia and hallucination
* at least one fall within the past 3 months or postural instability
* Gait disorder
* Hoehn and Yahr stages II-IV
* able to perform the treadmill therapy during a study
Exclusion Criteria
* Dementia as defined by an Montreal cognitive assessment (MOCA) \< 20
35 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinik Valens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veit Mylius
Priniciple Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veit Mylius, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Department of Neurology, Kliniken Valens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology
Valens, Canton of St. Gallen, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Veit Mylius, Prof. Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V1 19.09.2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.